Episode Details
Back to Episodes
PEXIVAS in ANCA Vasculitis
Description
Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis
Cast:
Joel Topf
Swapnil Hiremath
Samira Farouk
Jennie Lin
Jordy Cohen
Show Notes:
55th ERS-EDTA Congress, late breaking and high impact trials. June 2018
The CJASN Review recommended by Jennie
C5a antagonist, Avacopan in ANCA-Associated Vasculitis
The fragility index as described in JAMA Surgery
Michael Walsh looks at the Fragility Index in 399 trials in medical literature
The EVOLVE trial of Cinacalcet. Age-adjusted HR results in statistically significant results for primary outcome, but was not defined as the primary endpoint. Patients were one year older in the cinacalcet group; older age known to increase mortality in dialysis patients. Wiki Journal Club.
Ron Falk and his irresponsible editorial.
NephMadness is now in full swing at the AJKDblog!